Skip to main content
Supplement ScienceSupplementScience

L-Carnitine Side Effects & Safety

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Fishy body odor at higher doses due to trimethylamine production
  • Nausea, diarrhea, and abdominal cramps possible
  • High chronic doses may increase TMAO levels (potential cardiovascular concern)

Drug & Supplement Interactions

  • Anticoagulants (warfarin) — L-carnitine may enhance anticoagulant effects
  • Thyroid hormones — L-carnitine may inhibit thyroid hormone action peripherally
  • AZT and other nucleoside analogues — carnitine may help mitigate mitochondrial toxicity

Maximum Dose

Do not exceed: 3-6 g/day used safely; doses above 3 g may increase TMAO production (a cardiovascular risk marker)

References

  1. Meta-analysisDiNicolantonio JJ, Lavie CJ, Fares H, et al. (2013). L-Carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clinic Proceedings. DOI PubMed
  2. RCTSpiering BA, Kraemer WJ, Vingren JL, et al. (2007). Responses of criterion variables to different supplemental doses of L-carnitine L-tartrate. Journal of Strength and Conditioning Research. DOI PubMed
  3. Ma X, Yang Y, Liu S, Cui Y, et al. (2025). Meta-analysis of the efficacy and safety of L-carnitine and N-acetylcysteine monotherapy for male idiopathic infertility.. Revista internacional de andrologia. DOI PubMed
  4. Meta-analysisHamedi-Kalajahi F, Zarezadeh M, Malekahmadi M, Jamilian P, et al. (2025). The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis.. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. DOI PubMed
  5. Meta-analysisMirrafiei A, Jayedi A, Shab-Bidar S (2024). The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.. Clinical therapeutics. DOI PubMed
  6. Li Y, Xie Y, Qiu C, Yu B, et al. (2023). Effects of L-carnitine supplementation on glucolipid metabolism: a systematic review and meta-analysis.. Food & function. DOI PubMed
  7. Meta-analysisRastgoo S, Fateh ST, Nikbaf-Shandiz M, Rasaei N, et al. (2023). The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: a systematic review and dose-response meta-analysis.. Inflammopharmacology. DOI PubMed
Show 4 more references
  1. Guedes GV, Minicucci MF, Tanni SE (2022). The supplementation of L-carnitine in septic shock patients: Systematic review and meta-analysis.. Clinics (Sao Paulo, Brazil). DOI PubMed
  2. Mohd Shukri MF, Norhayati MN, Badrin S, Abdul Kadir A (2022). Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis.. PeerJ. DOI PubMed
  3. Wei G, Zhou Z, Cui Y, Huang Y, et al. (2021). A Meta-Analysis of the Efficacy of L-Carnitine/L-Acetyl-Carnitine or N-Acetyl-Cysteine in Men With Idiopathic Asthenozoospermia.. American journal of men's health. DOI PubMed
  4. Weng Y, Zhang S, Huang W, Xie X, et al. (2021). Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.. BioMed research international. DOI PubMed